Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2005
10/06/2005US20050221338 Novel fluorescent protein and gene encoding the same
10/06/2005US20050221335 Reporter gene
10/06/2005US20050221332 Corticotropin releasing hormone (CRH); pro-opiomelanocortin (POMC); distinguishing bovines having a CRH gene polymorphism; isolating a genomic DNA sample; amplifying; detecting a polymorphism present in the CRH gene at position 22
10/06/2005US20050221331 Osteoprotegerin
10/06/2005US20050221330 Glial cell line-derived neurotrophic factor (GDNF); nervous system disorders, autonomic nervous system, shingles, asthma, irritable bowel, inflammatory bowel, constipation, headache, arthritis, spinal cord injury, chronic back pain, hypertension, mucositis, diabetes, fibromyalgia, and wound healing
10/06/2005US20050221328 Inhibitors of inflammatory gene activity and cholesterol biosynthesis
10/06/2005US20050221327 Detecting integrin alpha 10 chain expressing mesenchymal stem cells (MSC) for use in tissue repair and/or regeneration
10/06/2005US20050221325 Detection of secreted polypeptides
10/06/2005US20050221317 Use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
10/06/2005US20050221311 Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and used thereof
10/06/2005US20050221308 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
10/06/2005US20050221303 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/06/2005US20050221301 Reference clones and sequences for non-subtype B isolates of human immunodeficiency virus type 1
10/06/2005US20050221299 Peptide from the glycoprotein B from human herpesvirus 7 for use in a serological ELISA test
10/06/2005US20050221297 Diagnostic reagent for hepatitis C virus infection
10/06/2005US20050221296 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay; antigenic peptides of HCV immobilized on solid substrate
10/06/2005US20050221295 Peptides from the E7 protein of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papilloma virus associated cancers
10/06/2005US20050221294 Inhibitors of HIV membrane fusion
10/06/2005US20050221292 Vectors with modified protease-dependent tropism
10/06/2005US20050221291 Dc-sign isoforms, related compositions and methods for their use in disease therapy
10/06/2005US20050221289 Altering viral tropism
10/06/2005US20050221288 Variant tat proteins and methods for use thereof
10/06/2005US20050221285 Method for identifying or screening anti-viral agents
10/06/2005US20050220886 Immobilized immunomodulators; antiinflammatory, anticarcinogenic agents, antiallergens; autoimmune diseases, asthma
10/06/2005US20050220817 Stabilized soluble glycoprotein trimers
10/06/2005US20050220816 Mutant viral nucleic acids and vaccine containing same
10/06/2005US20050220813 Non-spreading pestivirus
10/06/2005US20050220811 Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti
10/06/2005US20050220809 Nucleotide sequence coding for a tolc and a defined amino acid sequence
10/06/2005US20050220808 approximately 20-25 amino acids in length which are portions of the N termini of the M proteins of the most prevalent United States Group A Streptococcus serotypes; do not elicit tissue cross-reactive antibodies
10/06/2005US20050220807 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/06/2005US20050220806 Method of transporting physiological polymer using protein having rxp repeated sequence
10/06/2005US20050220805 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines
10/06/2005US20050220803 Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ
10/06/2005US20050220801 Immunopotentiators
10/06/2005US20050220800 Cytokines and cytokine receptors with reduced immunogenicity
10/06/2005US20050220797 Prophylactic and therapeutic monoclonal antibodies
10/06/2005US20050220792 Selective inhibition of NF-kappaB activation by peptides designed to disrupt NEMO oligomerization
10/06/2005US20050220790 Amino-terminally truncated rantes as chemokine antagonists
10/06/2005US20050220789 T cell immune response cDNA 7 (TIRC7) protein for use in treatment of organ transplantation rejection, tumor, autoimmune and/or allergic disorders
10/06/2005US20050220788 Use of molecules which interact with the haptoglobin receptor ligand binding
10/06/2005US20050220781 IFIX, a novel HIN-200 protein, for cancer therapy
10/06/2005US20050220767 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
10/06/2005US20050220765 Viruses with enhanced lytic potency
10/06/2005US20050220762 Modified human interferon polypeptides and their uses
10/06/2005US20050220759 Treating multiple sclerosis by orally administering an excipient and a RANTES polypeptide or a macrophage inflammatory protein; preventing autoimmune and inflammatory diseases and bacterial and viral infections
10/06/2005US20050220757 Chemokine mutants acting as chemokine antagonists
10/06/2005DE102004013847A1 Cyanidtolerante Nitrilhydratasen Cyanide-tolerant nitrile hydratase
10/06/2005DE102004013503A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung coryneformer Bakterien A process for the preparation of L-amino acids using coryneform bacteria
10/06/2005CA2563886A1 Compositions and methods for controlling insects related to the octopamine receptor
10/06/2005CA2561696A1 Novel modified galectin 9 proteins and use thereof
10/06/2005CA2561502A1 Marker gene for arthrorheumatism test
10/06/2005CA2561495A1 Truncated dance, dance complex and method of using these
10/06/2005CA2561377A1 Mussel bioadhesive
10/06/2005CA2560903A1 Use of emmprin antagonists for the treatment of diseases associated with excessive angiogenesis
10/06/2005CA2560434A1 Plants having increased seed yeild and/or growth rate and method for making same, comprising transformation with a nucleic acid encoding a 40s small subunit ribosomal protein
10/06/2005CA2559867A1 Method for screening agents modulating a lkb$g(a) protein ubiquitination and means for carrying out said method
10/06/2005CA2559536A1 Library of toxin mutants, and methods of using same
10/06/2005CA2558738A1 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
10/06/2005CA2558124A1 Chemokine ccl18 as a biomarker
10/06/2005CA2557782A1 Glycol linked fgf-21 compounds
10/06/2005CA2557677A1 In vitro test system for predicting patient tolerability of therapeutic agents
10/06/2005CA2557426A1 Rab9a, rab11a, and modulators thereof related to infectious disease
10/05/2005EP1582589A1 Protein complex, process for producing the same and use thereof
10/05/2005EP1582587A1 Cold-induced expression vector
10/05/2005EP1582586A1 Apoptosis-associated protein and use thereof
10/05/2005EP1582530A1 Diagnositc use of polymorphisms in the gene for BTNL2 associated with sarcoidosis
10/05/2005EP1582529A1 Mutant tyrosine repressor, a gene encoding the same, and a method for producing L-DOPA
10/05/2005EP1581812A2 Compositions and methods for diagnosing and treating colon cancers
10/05/2005EP1581652A2 Identification of sequences particularly useful for the diagnosis and identification of therapeutic targets for osteoarthritis
10/05/2005EP1581649A2 Binding agents which inhibit myostatin
10/05/2005EP1581648A2 G protein coupled receptors and uses thereof
10/05/2005EP1581643A2 Plant gene
10/05/2005EP1581641A2 Compositions, splice variants and methods relating to ovarian specific genes and proteins
10/05/2005EP1581638A1 P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof
10/05/2005EP1581632A2 Mutations affecting carotenoid production
10/05/2005EP1581631A2 Interferon variants with improved properties
10/05/2005EP1581629A2 Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy
10/05/2005EP1581628A2 A set of ubiquitous cellular proteins involved in viral life cycle
10/05/2005EP1581627A2 Yeast protein expression secretion system
10/05/2005EP1581625A2 Junctional adhesion molecule splice variants
10/05/2005EP1581622A2 Erythropoietin: remodeling and glycoconjugation of erythropoietin
10/05/2005EP1581621A2 Novel tumor suppressor gene and compositions and methods for making and using the same
10/05/2005EP1581618A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/05/2005EP1581616A2 Novel proteins and nucleic acids encoding same
10/05/2005EP1581614A2 Nucleotide sequences for gene regulation and methods of use thereof
10/05/2005EP1581560A1 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof
10/05/2005EP1581556A2 Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp)
10/05/2005EP1581555A2 G-proteins
10/05/2005EP1581554A2 Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof
10/05/2005EP1581552A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
10/05/2005EP1581551A2 F11 receptor(f11r) antagonists as therapeutic agents
10/05/2005EP1581550A2 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands, particulary of bothrops jararaca, vasopeptidases inhibitors, evasins, their analogues, derivatives and products associated, thereof. for development of aplications and use in chronic-degenerative diseases
10/05/2005EP1581542A2 Novel compositions and methods in cancer
10/05/2005EP1581307A2 Irs modulators
10/05/2005EP1581251A2 Human growth hormone crystals and methods for preparing them
10/05/2005EP1581247A1 Methods and compositions for treating polycystic ovary syndrome
10/05/2005EP1581244A1 Novel therapeutic targets in cancer
10/05/2005EP1581243A2 Oral lactoferrin in the treatment of sepsis
10/05/2005EP1581242A2 Compositions and methods for modifying toxic effects of proteinaceous compounds
1 ... 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 ... 2916